Oral Lynovex cysteamine regulatory update

FDA granted Orphan Drug designation to NovaBiotics' Lynovex cysteamine to treat cystic fibrosis. NovaBiotics is developing oral Lynovex for acute exacerbations of CF and an inhaled formulation of the ...